Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
JWA Polyclonal Antibody
JWA Polyclonal Antibody
Supplier: Thermo Scientific PA553319
Description
JWA Polyclonal Antibody for Western Blot, ICC/IF, IHC

Specifications
JWA | |
Polyclonal | |
Unconjugated | |
Arl6ip5 | |
5930404D22Rik; addicsin; addiscin; ADP ribosylation factor like GTPase 6 interacting protein 5; ADP-ribosylation factor GTPase 6 interacting protein 5; ADP-ribosylation factor like GTPase 6 interacting protein 5; ADP-ribosylation factor-like 6 interacting protein 5; ADP-ribosylation factor-like protein 6-interacting protein 5; ADP-ribosylation-like factor 6 interacting protein 5; Aip5; Aip-5; ARL-6-interacting protein 5; Arl6ip5; AV001879; cytoskeleton related vitamin A responsive protein; cytoskeleton-related vitamin A-responsive protein; dermal papilla derived protein 11; dermal papilla-derived protein 11; DERP11; glutamate transporter EAAC1 interacting protein; glutamate transporter EAAC1-interacting protein; glutamate transporter EEAC1-associated protein; GTRAP3-18; hp22; HSPC127; JM5; jmx; Jwa; PRA1 domain family 3; PRA1 family protein 3; Pra2; Praf3; Prenylated Rab acceptor protein 2; protein JWa; putative MAPK activating protein PM27; putative MAPK-activating protein PM27; Yip6b | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
10550 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
O75915 | |
Arl6ip5 | |
Recombinant protein corresponding to Human JWA. Recombinant protein control fragment (Product #RP-91079). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction